{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:21Z","timestamp":1790959161637,"version":"4.1.0"},"reference-count":283,"publisher":"Elsevier","isbn-type":[{"value":"9780323988377","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.acc.2021.09.006","type":"book-chapter","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T04:15:25Z","timestamp":1644466525000},"page":"181-234","source":"Crossref","is-referenced-by-count":67,"title":["Myostatin: Basic biology to clinical application"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.acc.2021.09.006_bb0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-\u03b2 superfamily member","volume":"387","author":"Mc Pherron","year":"1997","journal-title":"Nature"},{"key":"10.1016\/bs.acc.2021.09.006_bb0015","doi-asserted-by":"crossref","first-page":"R467","DOI":"10.1016\/S0960-9822(06)00238-7","article-title":"Growth control: action mouse","volume":"7","author":"Slack","year":"1997","journal-title":"Curr. Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/ng0997-71","article-title":"A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle","volume":"1","author":"Grobet","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/bs.acc.2021.09.006_bb0025","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1073\/pnas.151270098","article-title":"Regulation of myostatin activity and muscle growth","volume":"16","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.acc.2021.09.006_bb0030","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1101\/gr.7.9.910","article-title":"Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle","volume":"9","author":"Kambadur","year":"1997","journal-title":"Genome Res."},{"key":"10.1016\/bs.acc.2021.09.006_bb0035","first-page":"71","article-title":"From mighty mice to mighty cows","volume":"1","author":"Westhusin","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/bs.acc.2021.09.006_bb0040","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s003359900727","article-title":"Molecular definition of an allelic series of mutations disrupting the myostatin function and causing double-muscling in cattle","volume":"9","author":"Grobet","year":"1998","journal-title":"Mamm. Genome"},{"key":"10.1016\/bs.acc.2021.09.006_bb0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2527\/jas.2009-2385","article-title":"The two mutations Q204X and nt 821 of the myostatin gene affect carcass and meat quality in heterozygous young bulls of French beef breeds","volume":"88","author":"Allais","year":"2009","journal-title":"J. Anim. Sci."},{"key":"10.1016\/bs.acc.2021.09.006_bb0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2156-8-80","article-title":"Evidence for multiple alleles effecting muscling and fatness at the ovine GDF8 locus","volume":"8","author":"Kijas","year":"2007","journal-title":"BMC Genet."},{"key":"10.1016\/bs.acc.2021.09.006_bb0055","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2052.2008.01774.x","article-title":"Characterization of the complete porcine MYOSTATIN gene and expression levels in pig breeds differing in muscularity","volume":"39","author":"Stinckens","year":"2008","journal-title":"Anim. Genet."},{"key":"10.1016\/bs.acc.2021.09.006_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0030079","article-title":"A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs","volume":"3","author":"Mosher","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/bs.acc.2021.09.006_bb0065","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","article-title":"Myostatin mutation associated with gross muscle hypertrophy in a child","volume":"350","author":"Schuelke","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2021.09.006_bb0070","doi-asserted-by":"crossref","first-page":"14938","DOI":"10.1073\/pnas.95.25.14938","article-title":"Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting","volume":"25","author":"Gonzalez-Cadavid","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.acc.2021.09.006_bb0075","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1248\/bpb.b19-00513","article-title":"Sarcopenia in chronic kidney disease: factors, mechanisms, and therapeutic interventions","volume":"42","author":"Watanabe","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/bs.acc.2021.09.006_bb0080","first-page":"351","article-title":"GDF11\/myostatin and aging","volume":"5","author":"Patek","year":"2014","journal-title":"Aging"},{"key":"10.1016\/bs.acc.2021.09.006_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-981-10-6020-5_11","article-title":"Metabolic changes during cancer cachexia pathogenesis","volume":"1026","author":"Shyh-Chang","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0090","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrneph.2014.112","article-title":"Mechanisms of muscle wasting in chronic kidney disease","volume":"10","author":"Wang","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijcard.2007.07.058","article-title":"Hypothesis: myostatin is a mediator of cardiac cachexia","volume":"124","author":"Hoenig","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0100","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.biocel.2010.09.017","article-title":"Myostatin regulates glucose metabolism via the AMP-activated protein kinase pathway in skeletal muscle cells","volume":"12","author":"Chen","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI0213562","article-title":"Suppression of body fat accumulation in myostatin-deficient mice","volume":"109","author":"McPherron","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2021.09.006_bb0110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/db08-0943","article-title":"Increased secretion and expression of myostatin in skeletal muscle from extremely obese women","volume":"58","author":"Hittel","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/bs.acc.2021.09.006_bb0115","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1210\/jc.2003-032047","article-title":"Changes in muscle myostatin expression in obese subjects after weight loss","volume":"6","author":"Milan","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2021.09.006_bb0120","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00125-011-2079-7","article-title":"Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway","volume":"54","author":"Zhang","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/bs.acc.2021.09.006_bb0125","article-title":"Plasma and muscle myostatin in relation to type 2 diabetes","volume":"5","author":"Brandt","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2021.09.006_bb0130","article-title":"Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways","volume":"8","author":"Palsgaard","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2021.09.006_bb0135","first-page":"550","article-title":"Serum myostatin is upregulated in obesity and correlates with insulin resistance in humans","volume":"8","author":"Amor","year":"2019","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/bs.acc.2021.09.006_bb0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00125-011-2304-4","article-title":"Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice","volume":"55","author":"Zhang","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/bs.acc.2021.09.006_bb0145","doi-asserted-by":"crossref","first-page":"34911","DOI":"10.18632\/oncotarget.16822","article-title":"Loss-of-function myostatin mutation increases insulin sensitivity and browning of white fat in Meishan pigs","volume":"8","author":"Cai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/bs.acc.2021.09.006_bb0150","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ijo.2015.200","article-title":"Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues","volume":"40","author":"Dong","year":"2016","journal-title":"Int. J. Obes."},{"key":"10.1016\/bs.acc.2021.09.006_bb0155","doi-asserted-by":"crossref","first-page":"19371","DOI":"10.1074\/jbc.M802585200","article-title":"Myostatin directly regulates skeletal muscle fibrosis","volume":"283","author":"Li","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2021.09.006_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023818","article-title":"Myostatin is elevated in congenital heart disease and after mechanical unloading","volume":"6","author":"Bish","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2021.09.006_bb0165","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.dld.2019.03.002","article-title":"Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation","volume":"10","author":"Delogu","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/bs.acc.2021.09.006_bb0170","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nm.3917","article-title":"Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice","volume":"9","author":"Dankbar","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/bs.acc.2021.09.006_bb0175","doi-asserted-by":"crossref","first-page":"46362","DOI":"10.1038\/srep46362","article-title":"Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment","volume":"7","author":"Verzola","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2021.09.006_bb0180","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.5551\/jat.51144","article-title":"Myostatin in the arterial wall of patients with end-stage renal disease","volume":"27","author":"Esposito","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/bs.acc.2021.09.006_bb0185","series-title":"Growth Factors and Cytokines in Health and Disease","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1874-5687(96)80016-4","article-title":"The transforming growth factor-b superfamily","volume":"vol. 1B","author":"McPherron","year":"1996"},{"key":"10.1016\/bs.acc.2021.09.006_bb0190","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08977190109029114","article-title":"GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding","volume":"18","author":"Thies","year":"2001","journal-title":"Growth Factors"},{"key":"10.1016\/bs.acc.2021.09.006_bb0195","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1126\/science.1069525","article-title":"Induction of cachexia in mice by systemically administered myostatin","volume":"296","author":"Zimmers","year":"2002","journal-title":"Science"},{"key":"10.1016\/bs.acc.2021.09.006_bb0200","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bbrc.2004.01.085","article-title":"Characterization and identification of the inhibitory domain of GDF-8 propeptide","volume":"315","author":"Jiang","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2021.09.006_bb0205","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.2315700","article-title":"Requirement for activin A and transforming growth factor-beta 1 pro-regions in homodimer assembly","volume":"247","author":"Gray","year":"1990","journal-title":"Science"},{"key":"10.1016\/bs.acc.2021.09.006_bb0210","doi-asserted-by":"crossref","first-page":"E866","DOI":"10.1073\/pnas.1714622115","article-title":"Molecular characterization of latent GDF8 reveals mechanisms of activation","volume":"115","author":"Walker","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.acc.2021.09.006_bb0215","doi-asserted-by":"crossref","first-page":"15842","DOI":"10.1073\/pnas.2534946100","article-title":"Activation of latent myostatin by the BMP-1\/tolloid family of metalloproteinases","volume":"26","author":"Wolfman","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.acc.2021.09.006_bb0220","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1074\/jbc.M706678200","article-title":"Identification of a novel pool of extracellular pro-myostatin in skeletal muscle","volume":"283","author":"Anderson","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2021.09.006_bb0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.febslet.2014.12.011","article-title":"K153R polymorphism in myostatin gene increases the rate of promyostatin activation by furin","volume":"589","author":"Szl\u00e1ma","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/bs.acc.2021.09.006_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001628","article-title":"Genetic analysis of the role of proteolysis in the activation of latent myostatin","volume":"3","author":"Lee","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2021.09.006_bb0235","doi-asserted-by":"crossref","first-page":"E1128","DOI":"10.1152\/ajpendo.2001.281.6.E1128","article-title":"Characterization of 5\u2032-regulatory region of human myostatin gene: regulation by dexamethasone in vitro","volume":"281","author":"Ma","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2021.09.006_bb0240","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/dbio.1999.9345","article-title":"An E box comprises a positional sensor for regional differences in skeletal muscle gene expression and methylation","volume":"213","author":"Ceccarelli","year":"1999","journal-title":"Dev. Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0245","article-title":"Myostatin gene promoter: structure, conservation and importance as a target for muscle modulation","volume":"10","author":"Carvalho-Grade","year":"2019","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0250","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1128\/MCB.22.20.7066-7082.2002","article-title":"The myostatin gene is a downstream target gene of basic helix-loop-helix transcription factor MyoD","volume":"22","author":"Spiller","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0255","doi-asserted-by":"crossref","first-page":"49831","DOI":"10.1074\/jbc.M204291200","article-title":"Myostatin inhibits myoblast differentiation by down-regulating Myod expression","volume":"277","author":"Langley","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2021.09.006_bb0260","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/bj20020508","article-title":"CCAAT\/enhancer-binding proteins: structure, function and regulation","author":"Ramji","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/bs.acc.2021.09.006_bb0265","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1152\/japplphysiol.90780.2008","article-title":"Effects of spaceflight on murine skeletal muscle gene expression","volume":"106","author":"Allen","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0270","doi-asserted-by":"crossref","first-page":"R1592","DOI":"10.1152\/ajpregu.00247.2010","article-title":"CCAAT\/enhancer binding protein-delta expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro","volume":"299","author":"Allen","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0275","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","article-title":"Stat3 activation links a C\/EBPd to myostatin pathway to stimulate loss of muscle mass","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/bs.acc.2021.09.006_bb0280","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11033-017-4126-z","article-title":"CREB, NF-Y and MEIS1 conserved binding sites are essential to balance myostatin promoter\/enhancer activity during early myogenesis","volume":"44","author":"Grade","year":"2017","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/bs.acc.2021.09.006_bb0285","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbrc.2013.09.067","article-title":"The cAMP response element binding protein (CREB) is activated by insulin-like growth factor-1 (IGF-1) and regulates myostatin gene expression in skeletal myoblast","volume":"440","author":"Zuloaga","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2021.09.006_bb0290","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.bbrc.2018.07.056","article-title":"Glucocorticoid-induced CREB activation and myostatin expression in C2C12 myotubes involves phosphodiesterase-3\/4 signaling","volume":"503","author":"Xie","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2021.09.006_bb0295","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00018-013-1513-z","article-title":"FoxO transcription factors: their roles in the maintenance of skeletal muscle homeostasis","volume":"71","author":"Sanchez","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/bs.acc.2021.09.006_bb0300","doi-asserted-by":"crossref","first-page":"C188","DOI":"10.1152\/ajpcell.00542.2005","article-title":"Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors","volume":"291","author":"Allen","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0305","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.18632\/oncotarget.12891","article-title":"FoxO1: a novel insight into its molecular mechanisms in the regulation of skeletal muscle differentiation and fiber type specification","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/bs.acc.2021.09.006_bb0310","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1474-9726.2011.00734.x","article-title":"Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-\u03baB","volume":"10","author":"Sriram","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/bs.acc.2021.09.006_bb0315","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1096\/fj.10-176917","article-title":"Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease","volume":"25","author":"Zhang","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/bs.acc.2021.09.006_bb0320","doi-asserted-by":"crossref","first-page":"18162","DOI":"10.1073\/pnas.1317049110","article-title":"Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-\u03baB-mediated mechanism","volume":"110","author":"Qiu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.acc.2021.09.006_bb0325","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ceb.2007.04.011","article-title":"Genomic patterns of DNA methylation: targets and function of an epigenetic mark","volume":"19","author":"Weber","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0330","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/hdy.2010.54","article-title":"Epigenetics and gene expression","volume":"105","author":"Gibney","year":"2010","journal-title":"Heredity"},{"key":"10.1016\/bs.acc.2021.09.006_bb0335","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/jcb.22740","article-title":"Transcription activation of myostatin by trichostatin A in differentiated C2C12 myocytes via ASK1-MKK3\/4\/6-JNK and p38 mitogen-activated protein kinase pathways","volume":"111","author":"Han","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/bs.acc.2021.09.006_bb0340","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1152\/japplphysiol.01031.2014","article-title":"Trichostatin A, a histone deacetylase inhibitor, modulates unloaded-induced skeletal muscle atrophy","volume":"119","author":"Dupr\u00e9-Aucouturier","year":"2015","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0345","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/ar.22972","article-title":"SMYD proteins: key regulators in skeletal and cardiac muscle development and function","volume":"297","author":"Du","year":"2014","journal-title":"Anat. Rec."},{"key":"10.1016\/bs.acc.2021.09.006_bb0350","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1101\/gad.217240.113","article-title":"The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy","volume":"27","author":"Proserpio","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/bs.acc.2021.09.006_bb0355","doi-asserted-by":"crossref","first-page":"899","DOI":"10.4161\/epi.6.7.16005","article-title":"Maternal dietary protein affects transcriptional regulation of myostatin gene distinctively at weaning and finishing stages in skeletal muscle of Meishan pigs","volume":"6","author":"Liu","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/bs.acc.2021.09.006_bb0360","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00394-015-0949-3","article-title":"Low-protein diet fed to crossbred sows during pregnancy and lactation enhances myostatin gene expression through epigenetic regulation in skeletal muscle of weaning piglets","volume":"55","author":"Jia","year":"2016","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/bs.acc.2021.09.006_bb0365","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.4161\/epi.22609","article-title":"Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells","volume":"7","author":"Fan","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/bs.acc.2021.09.006_bb0370","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tcb.2006.12.007","article-title":"Repression of protein synthesis by miRNAs: how many mechanisms?","volume":"17","author":"Pillai","year":"2007","journal-title":"Trends Cell Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2015.12.013","article-title":"Muscle-specific microRNAs in skeletal muscle development","volume":"410","author":"Horak","year":"2016","journal-title":"Dev. Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0380","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/ng1810","article-title":"A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep","volume":"38","author":"Clop","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/bs.acc.2021.09.006_bb0385","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3945\/jn.109.112797","article-title":"Essential amino acids increase microRNA-499, -208b, and -23a and downregulate myostatin and myocyte enhancer factor 2C mRNA expression in human skeletal muscle","volume":"139","author":"Drummond","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/bs.acc.2021.09.006_bb0390","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1139\/gen-2018-0110","article-title":"An integrated analysis of mRNA and miRNA in skeletal muscle from myostatin-edited Meishan pigs","volume":"62","author":"Xie","year":"2019","journal-title":"Genome"},{"key":"10.1016\/bs.acc.2021.09.006_bb0395","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1128\/MCB.01370-09","article-title":"Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping","volume":"30","author":"Bell","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0400","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1172\/JCI36154","article-title":"MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice","volume":"119","author":"Callis","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2021.09.006_bb0405","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fphys.2013.00408","article-title":"Role of microRNAs in skeletal muscle hypertrophy","volume":"4","author":"Hitachi","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0410","doi-asserted-by":"crossref","first-page":"C124","DOI":"10.1152\/ajpcell.00142.2010","article-title":"Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle","volume":"300","author":"Allen","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0415","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbrc.2012.05.106","article-title":"MicroRNA-27a promotes myoblast proliferation by targeting myostatin","volume":"423","author":"Huang","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2021.09.006_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087687","article-title":"Negative auto-regulation of myostatin expression is mediated by Smad3 and microRNA-27","volume":"9","author":"McFarlane","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2021.09.006_bb0425","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1681\/ASN.2016111213","article-title":"MicroRNA-23a and microRNA-27a mimic exercise by ameliorating CKD-induced muscle atrophy","volume":"28","author":"Wang","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008760","article-title":"Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice","volume":"5","author":"Panguluri","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2021.09.006_bb0435","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/jcsm.12296","article-title":"miRNA-23a\/27a attenuates muscle atrophy and renal fibrosis through muscle-kidney crosstalk","volume":"9","author":"Zhang","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/bs.acc.2021.09.006_bb0440","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","article-title":"Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN","volume":"95","author":"Stambolic","year":"1998","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2021.09.006_bb0445","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biocel.2013.12.003","article-title":"Myostatin signaling regulates Akt activity via the regulation of miR-486 expression","volume":"47","author":"Hitachi","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0450","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ki.2012.84","article-title":"Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486","volume":"82","author":"Xu","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/bs.acc.2021.09.006_bb0455","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1096\/fasebj.11.1.9034166","article-title":"Growth factors in the extracellular matrix","volume":"11","author":"Taipale","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/bs.acc.2021.09.006_bb0460","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/jcb.23385","article-title":"LTBPs, more than just an escort service","volume":"113","author":"Todorovic","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/bs.acc.2021.09.006_bb0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006019","article-title":"Overexpression of latent TGF\u03b2 binding protein 4 in muscle ameliorates muscular dystrophy through myostatin and TGF\u03b2","volume":"12","author":"Lamar","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/bs.acc.2021.09.006_bb0470","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1740-0929.2009.00700.x","article-title":"Interaction between myostatin and extracellular matrix components","volume":"81","author":"Miura","year":"2010","journal-title":"Anim. Sci. J."},{"key":"10.1016\/bs.acc.2021.09.006_bb0475","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.nmd.2012.07.002","article-title":"Identification of decorin derived peptides with a zinc dependent anti-myostatin activity","volume":"22","author":"Guiraud","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/bs.acc.2021.09.006_bb0480","first-page":"258","article-title":"Decorin binds myostatin and modulates its activity to muscle cells","volume":"440","author":"Miura","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2021.09.006_bb0485","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12565-009-0039-9","article-title":"Increased expression of decorin during the regeneration stage of mdx mouse","volume":"84","author":"Abe","year":"2009","journal-title":"Anat. Sci. Int."},{"key":"10.1016\/bs.acc.2021.09.006_bb0490","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/CIRCULATIONAHA.115.016423","article-title":"Glycoproteomics reveals decorin peptides with anti-myostatin activity in human atrial fibrillation","volume":"134","author":"Barallobre-Barreiro","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2021.09.006_bb0495","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-5793(97)01108-3","article-title":"Telethonin, a novel sarcomeric protein of heart and skeletal muscle","volume":"415","author":"Valle","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/bs.acc.2021.09.006_bb0500","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/jcp.10158","article-title":"Titin-cap associates with, and regulates secretion of myostatin","volume":"193","author":"Nicholas","year":"2002","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0505","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/hmg\/ddq105","article-title":"Functional muscle analysis of the Tcap knockout mouse","volume":"19","author":"Markert","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/bs.acc.2021.09.006_bb0510","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1073\/pnas.84.23.8282","article-title":"Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone","volume":"84","author":"Ueno","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S.A."},{"key":"10.1016\/bs.acc.2021.09.006_bb0515","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1051\/rnd:2005031","article-title":"Testing the antagonistic effect of follistatin on BMP family members in ovine granulosa cells","volume":"45","author":"Pierre","year":"2005","journal-title":"Reprod. Nutr. Dev."},{"key":"10.1016\/bs.acc.2021.09.006_bb0520","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1210\/en.2006-0089","article-title":"Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins","volume":"147","author":"Sidis","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2021.09.006_bb0525","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ydbio.2004.01.046","article-title":"Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis","volume":"270","author":"Amthor","year":"2004","journal-title":"Dev. Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0530","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1210\/me.2012-1061","article-title":"Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism","volume":"26","author":"Cash","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0535","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1073\/pnas.85.12.4218","article-title":"Primary structure of the human follistatin precursor and its genomic organization","volume":"85","author":"Shimasaki","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.acc.2021.09.006_bb0540","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/frne.1998.0169","article-title":"Follistatin: a multifunctional regulatory protein","volume":"19","author":"Phillips","year":"1998","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0545","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/en.2004-1041","article-title":"Heparin and activin-binding determinants in follistatin and FSTL3","volume":"146","author":"Sidis","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2021.09.006_bb0550","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1038\/emboj.2009.205","article-title":"The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding","volume":"28","author":"Cash","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/bs.acc.2021.09.006_bb0555","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1515\/BC.2002.023","article-title":"Distinct expression pattern of two related human proteins containing multiple types of protease-inhibitory modules","volume":"383","author":"Trexler","year":"2002","journal-title":"Biol. Chem."},{"key":"10.1016\/bs.acc.2021.09.006_bb0560","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1210\/me.2002-0366","article-title":"Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains","volume":"17","author":"Hill","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0565","doi-asserted-by":"crossref","first-page":"E3713","DOI":"10.1073\/pnas.1309907110","article-title":"Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2","volume":"110","author":"Lee","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.acc.2021.09.006_bb0570","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1159\/000485878","article-title":"Alterations in adiposity and glucose homeostasis in adult Gasp-1 overexpressing mice","volume":"44","author":"Perie","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/bs.acc.2021.09.006_bb0575","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1096\/fj.201901220R","article-title":"GASP-2 overexpressing mice exhibit a hypermuscular phenotype with contrasting molecular effects compared to GASP-1 transgenics","volume":"34","author":"Parent\u00e9","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/bs.acc.2021.09.006_bb0580","doi-asserted-by":"crossref","first-page":"21037","DOI":"10.1074\/jbc.M110.114959","article-title":"Characterization of the ligand binding functionality of the extracellular domain of activin receptor type IIb","volume":"285","author":"Sako","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2021.09.006_bb0585","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1128\/MCB.23.20.7230-7242.2003","article-title":"Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis","volume":"23","author":"Rebbapragada","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0590","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1096\/fj.11-191189","article-title":"Cell-type specific regulation of myostatin signaling","volume":"26","author":"Kemaladewi","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/bs.acc.2021.09.006_bb0595","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrm1017","article-title":"Caveolae-from ultrastructure to molecular mechanism","volume":"4","author":"Parton","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0600","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1172\/JCI28520","article-title":"Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition","volume":"11","author":"Ohsawa","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2021.09.006_bb0605","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s13105-012-0192-9","article-title":"Overexpression of caveolin-3-enhanced protein synthesis rather than proteolysis inhibition in C2C12 myoblasts: relationship with myostatin activity","volume":"68","author":"Hadj Sassi","year":"2012","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/bs.acc.2021.09.006_bb0610","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-\u03b2 signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2021.09.006_bb0615","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1242\/jcs.114.24.4359","article-title":"Smad regulation in TGF-beta signal transduction","volume":"114","author":"Moustakas","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/bs.acc.2021.09.006_bb0620","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cyto.2004.03.007","article-title":"Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism","volume":"26","author":"Zhu","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/bs.acc.2021.09.006_bb0625","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/cr.2011.72","article-title":"Smad3 signaling is required for satellite cell function and myogenic differentiation of myoblasts","volume":"21","author":"Ge","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/bs.acc.2021.09.006_bb0630","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.7150\/ijbs.40551","article-title":"MSTN mutant promotes myogenic differentiation by increasing demethylase TET1 expression via the SMAD2\/SMAD3 pathway","volume":"16","author":"Gao","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/bs.acc.2021.09.006_bb0635","doi-asserted-by":"crossref","first-page":"C1248","DOI":"10.1152\/ajpcell.00104.2009","article-title":"Smad2 and 3 transcription factors control muscle mass in adulthood","volume":"296","author":"Sartori","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0640","doi-asserted-by":"crossref","first-page":"12184","DOI":"10.1074\/jbc.M115.680579","article-title":"Smad2\/3 proteins are required for immobilization-induced skeletal muscle atrophy","volume":"291","author":"Tando","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2021.09.006_bb0645","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/STROKEAHA.114.008574","article-title":"Molecular mechanisms of skeletal muscle atrophy in a mouse model of cerebral ischemia","volume":"46","author":"Desgeorges","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/bs.acc.2021.09.006_bb0650","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1210\/me.2013-1194","article-title":"Smad3 induces atrogin-1 inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo","volume":"27","author":"Goodman","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0655","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12020-012-9751-7","article-title":"Atrogin-1, MuRF-1, and sarcopenia","volume":"43","author":"Gumucio","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/bs.acc.2021.09.006_bb0660","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ncb1117","article-title":"Akt interacts directly with Smad3 to regulate the sensitivity to TGF-\u03b2-induced apoptosis","volume":"6","author":"Conery","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0665","first-page":"153","article-title":"Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions","volume":"22","author":"Pearson","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/bs.acc.2021.09.006_bb0670","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cellsig.2004.08.003","article-title":"Regulation of GDF-8 signaling by the p38 MAPK","volume":"17","author":"Philip","year":"2005","journal-title":"Cell. Signal."},{"key":"10.1016\/bs.acc.2021.09.006_bb0675","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.cellsig.2007.07.002","article-title":"Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells","volume":"19","author":"Huang","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/bs.acc.2021.09.006_bb0680","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1158\/0008-5472.CAN-05-3060","article-title":"Extracellular signal-regulated kinase 1\/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/bs.acc.2021.09.006_bb0685","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3389\/fimmu.2017.01747","article-title":"Myostatin promotes interleukin-1\u03b2 expression in rheumatoid arthritis synovial fibroblasts through inhibition of mir-21-5p","volume":"8","author":"Hu","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0690","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1210\/me.2013-1179","article-title":"Myostatin augments muscle-specific ring finger protein-1 expression through an NF-kB independent mechanism in SMAD3 null muscle","volume":"28","author":"Sriram","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013604","article-title":"Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition","volume":"5","author":"Penna","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.acc.2021.09.006_bb0700","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13367","article-title":"Myokines in skeletal muscle physiology and metabolism: recent advances and future perspectives","volume":"228","author":"Das","year":"2020","journal-title":"Acta Physiol. (Oxf.)"},{"key":"10.1016\/bs.acc.2021.09.006_bb0705","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1249\/00005768-198910001-00008","article-title":"Analysis of muscle regeneration using single myofibers in culture","volume":"21","author":"Bischoff","year":"1989","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/bs.acc.2021.09.006_bb0710","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1083\/jcb.200207056","article-title":"Myostatin negatively regulates satellite cell activation and self-renewal","volume":"162","author":"McCroskery","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0715","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1210\/en.2006-1500","article-title":"Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression","volume":"148","author":"Durieux","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2021.09.006_bb0720","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fphys.2017.00788","article-title":"mTOR as a key regulator in maintaining skeletal muscle mass","volume":"8","author":"Yoon","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0725","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1210\/en.2008-0959","article-title":"Down-regulation of Akt\/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle","volume":"150","author":"Amirouche","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2021.09.006_bb0730","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.febslet.2010.04.039","article-title":"Mechanisms involved in the enhancement of mammalian target of rapamycin signalling and hypertrophy in skeletal muscle of myostatin-deficient mice","volume":"584","author":"Lipina","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/bs.acc.2021.09.006_bb0735","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1074\/jbc.M610185200","article-title":"Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase\/AKT\/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1","volume":"282","author":"Yang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2021.09.006_bb0740","doi-asserted-by":"crossref","first-page":"40235","DOI":"10.1074\/jbc.M004356200","article-title":"Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation","volume":"275","author":"Thomas","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2021.09.006_bb0745","doi-asserted-by":"crossref","first-page":"R1518","DOI":"10.1152\/ajpregu.2001.280.5.R1518","article-title":"Increased muscle ubiquitin mRNA levels in gastric cancer patients","volume":"280","author":"Bossola","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0750","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/bbrc.1996.5827","article-title":"TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles","volume":"230","author":"Llovera","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2021.09.006_bb0755","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1007\/s00018-014-1689-x","article-title":"Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways","volume":"71","author":"Rodriguez","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/bs.acc.2021.09.006_bb0760","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jcp.20757","article-title":"Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism","volume":"209","author":"McFarlane","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0765","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cmet.2007.11.001","article-title":"FoxO3 controls autophagy in skeletal muscle in vivo","volume":"6","author":"Mammucari","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/bs.acc.2021.09.006_bb0770","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbrc.2011.10.124","article-title":"Myostatin induces autophagy in skeletal muscle in vitro","volume":"415","author":"Lee","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2021.09.006_bb0775","article-title":"Myostatin activates the ubiquitin-proteasome and autophagy-lysosome systems contributing to muscle wasting in chronic kidney disease","volume":"684965","author":"Wang","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/bs.acc.2021.09.006_bb0780","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.cgt.7701091","article-title":"Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice","volume":"14","author":"Liu","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/bs.acc.2021.09.006_bb0785","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/bs.acc.2021.09.006_bb0790","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ccachexia\u2013anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin. Nutr."},{"key":"10.1016\/bs.acc.2021.09.006_bb0795","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3390\/nu12051293","article-title":"Sarcopenia: a contemporary health problem among older adult populations","volume":"12","author":"Papadopoulou","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/bs.acc.2021.09.006_bb0800","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000356740","article-title":"Myostatin and sarcopenia: opportunities and challenges\u2014a mini-review","volume":"60","author":"White","year":"2014","journal-title":"Gerontology"},{"key":"10.1016\/bs.acc.2021.09.006_bb0805","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cger.2016.08.002","article-title":"Pathogenesis and management of sarcopenia","volume":"33","author":"Dhillon","year":"2017","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/bs.acc.2021.09.006_bb0810","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.exger.2016.01.016","article-title":"Protective effect of myostatin gene deletion on aging-related muscle metabolic decline","volume":"78","author":"Chabi","year":"2016","journal-title":"Exp. Gerontol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0815","first-page":"343","article-title":"Serum myostatin-immunoreactive protein is increased in 60- to 92-year-old women and men with muscle wasting","volume":"6","author":"Yarasheski","year":"2002","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/bs.acc.2021.09.006_bb0820","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0531-5565(02)00025-6","article-title":"Insulin-like growth factor-1 and myostatin MRNA expression in muscle: comparison between 62\u201377 and 21\u201331 year old men","volume":"37","author":"Welle","year":"2002","journal-title":"Exp. Gerontol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0825","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/gerona\/glr025","article-title":"Serum concentrations of myostatin and myostatin interacting proteins do not differ between young and sarcopenic elderly men","volume":"6","author":"Ratkevicius","year":"2011","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/bs.acc.2021.09.006_bb0830","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.cellbio.20.012103.135836","article-title":"Regulation of muscle mass by myostatin","volume":"20","author":"Lee","year":"2004","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0835","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","article-title":"Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies","volume":"14","author":"Batsis","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0840","article-title":"Physical activity and exercise: strategies to manage frailty","volume":"101513","author":"Angulo","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2020.110869","article-title":"The effects of concurrent training order on body composition and serum concentrations of follistatin, myostatin and GDF11 in sarcopenic elderly men","volume":"133","author":"Bagheri","year":"2020","journal-title":"Exp. Gerontol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0850","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000494137","article-title":"Serum myostatin levels are higher in fitter, more active, and non-frail long-term nursing home residents and increase after a physical exercise intervention","volume":"65","author":"Arrieta","year":"2019","journal-title":"Gerontology"},{"key":"10.1016\/bs.acc.2021.09.006_bb0855","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/gerona\/glp068","article-title":"Myostatin inhibition enhances the effects on performance and metabolic outcomes in aged mice","volume":"64","author":"Lebrasseur","year":"2009","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/bs.acc.2021.09.006_bb0860","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1096\/fj.10-159608","article-title":"Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function","volume":"24","author":"Murphy","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/bs.acc.2021.09.006_bb0865","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mus.23539","article-title":"A single ascending- dose study of muscle regulator ACE-031 in healthy volunteers","volume":"47","author":"Attie","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/bs.acc.2021.09.006_bb0870","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0875","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jamda.2010.02.004","article-title":"Consensus on cachexia definitions","volume":"11","author":"Argil\u00e9s","year":"2010","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/bs.acc.2021.09.006_bb0880","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/1874609811104030260","article-title":"Skeletal muscle protein balance and metabolism in the elderly","volume":"4","author":"Fry","year":"2011","journal-title":"Curr. Aging Sci."},{"key":"10.1016\/bs.acc.2021.09.006_bb0885","doi-asserted-by":"crossref","DOI":"10.1097\/MOG.0b013e3283347e77","article-title":"Cancer cachexia","volume":"26","author":"Tisdale","year":"2010","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0890","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13539-011-0035-5","article-title":"The role of myostatin in muscle wasting: an overview","volume":"2","author":"Elkina","year":"2001","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/bs.acc.2021.09.006_bb0895","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.redox.2018.09.009","article-title":"Myostatin knockout induces apoptosis in human cervical cancer cells via elevated reactive oxygen species generation","volume":"19","author":"Han","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0900","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/jcp.24611","article-title":"Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness","volume":"229","author":"Chacon-Cabrera","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0905","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","article-title":"Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia","volume":"391","author":"Benny Klimek","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2021.09.006_bb0910","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13539-011-0049-z","article-title":"Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance","volume":"3","author":"Busquets","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/bs.acc.2021.09.006_bb0915","doi-asserted-by":"crossref","first-page":"R716","DOI":"10.1152\/ajpregu.00121.2011","article-title":"Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice","volume":"301","author":"Murphy","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0920","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1158\/0008-5472.CAN-14-0057","article-title":"Myostatin gene inactivation prevents skeletal muscle wasting in cancer","volume":"74","author":"Gallot","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/bs.acc.2021.09.006_bb0925","doi-asserted-by":"crossref","first-page":"30340","DOI":"10.1038\/srep30340","article-title":"Autophagy is induced in the skeletal muscle of cachectic cancer patients","volume":"6","author":"Aversa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2021.09.006_bb0930","doi-asserted-by":"crossref","first-page":"12544","DOI":"10.1523\/JNEUROSCI.0829-06.2006","article-title":"Neurocytoma is a tumor of adult neuronal progenitor cells","volume":"26","author":"Sim","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.acc.2021.09.006_bb0935","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1245\/s10434-011-1720-5","article-title":"Changes in myostatin signaling in non-weight-losing cancer patients","volume":"19","author":"Aversa","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0940","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/mus.23945","article-title":"Gastric cancer does not affect the expression of atrophy-related genes in human skeletal muscle","volume":"49","author":"D'Orlando","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/bs.acc.2021.09.006_bb0945","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","article-title":"Wasting as independent risk factor for mortality in chronic heart failure","volume":"349","author":"Anker","year":"1997","journal-title":"Lancet (London, England)"},{"key":"10.1016\/bs.acc.2021.09.006_bb0950","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.96.2.526","article-title":"Hormonal changes and catabolic\/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia","volume":"96","author":"Anker","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2021.09.006_bb0955","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cardiores.2007.02.023","article-title":"Developmental expression of myostatin in cardiomyocytes and its effect on foetal and neonatal rat cardiomyocyte proliferation","volume":"74","author":"McKoy","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/bs.acc.2021.09.006_bb0960","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(199907)180:1<1::AID-JCP1>3.0.CO;2-V","article-title":"Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct","volume":"180","author":"Sharma","year":"1999","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0965","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2362.2006.01718.x","article-title":"Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure","volume":"36","author":"Shyu","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/bs.acc.2021.09.006_bb0970","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010230","article-title":"Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model","volume":"5","author":"Bish","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2021.09.006_bb0975","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/eurjhf\/hfq039","article-title":"Myostatin activation in patients with advanced heart failure and after mechanical unloading","volume":"12","author":"George","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/bs.acc.2021.09.006_bb0980","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.109.882068","article-title":"Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure","volume":"121","author":"Heineke","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2021.09.006_bb0985","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1741826711402735","article-title":"Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure","volume":"19","author":"Lenk","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb0990","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1183\/09031936.94.07101793","article-title":"Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD","volume":"7","author":"Engelen","year":"1994","journal-title":"Eur. Respir. J."},{"key":"10.1016\/bs.acc.2021.09.006_bb0995","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/ajcn\/82.1.53","article-title":"Body composition and mortality in chronic obstructive pulmonary disease","volume":"82","author":"Schols","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/bs.acc.2021.09.006_bb1000","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2169\/internalmedicine.48.1102","article-title":"Extent of emphysema on HRCT affects loss of fat-free mass and fat mass in COPD","volume":"48","author":"Kurosaki","year":"2009","journal-title":"Intern. Med."},{"issue":"9","key":"10.1016\/bs.acc.2021.09.006_bb1005","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1152\/japplphysiol.00790.2012","article-title":"The mechanisms of cachexia underlying muscle dysfunction in COPD","volume":"114","author":"Remels","year":"2013","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1010","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/SPC.0b013e328331e91c","article-title":"The pathophysiology of cachexia in chronic obstructive pulmonary disease","volume":"3","author":"Schols","year":"2009","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/bs.acc.2021.09.006_bb1015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mce.2010.09.008","article-title":"Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli","volume":"332","author":"Hayot","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1165\/rcmb.2008-0382OC","article-title":"Cellular markers of muscle atrophy in chronic obstructive pulmonary disease","volume":"42","author":"Plant","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1025","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1183\/09031936.00032510","article-title":"Quadriceps myostatin expression in COPD","volume":"36","author":"Man","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/bs.acc.2021.09.006_bb1030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.rmed.2011.07.016","article-title":"Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease","volume":"106","author":"Ju","year":"2012","journal-title":"Respir. Med."},{"key":"10.1016\/bs.acc.2021.09.006_bb1035","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.3748\/wjg.v20.i25.8061","article-title":"Clinical relevance of sarcopenia in patients with cirrhosis","volume":"20","author":"Montano-Loza","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1040","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/lt.23495","article-title":"Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value","volume":"18","author":"Tandon","year":"2012","journal-title":"Liver Transpl."},{"key":"10.1016\/bs.acc.2021.09.006_bb1045","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00535-019-01605-6","article-title":"Sarcopenia in cirrhosis: from pathogenesis to interventions","volume":"54","author":"Ebadi","year":"2019","journal-title":"J. Gastroenterol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3350\/cmh.2019.0015","article-title":"Sarcopenia: Ammonia metabolism and hepatic encephalopathy","volume":"25","author":"Jindal","year":"2019","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1055","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/jcsm.12262","article-title":"Myostatin and beyond in cirrhosis: all roads lead to sarcopenia","volume":"8","author":"Dasarathy","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/bs.acc.2021.09.006_bb1060","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1213\/ANE.0b013e3181eac1c9","article-title":"Brief-reports: elevated myostatin levels in patients with liver disease: a potential contributor to skeletal muscle wasting","volume":"111","author":"Garcia","year":"2010","journal-title":"Anesth. Analg."},{"key":"10.1016\/bs.acc.2021.09.006_bb1065","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jhep.2010.08.032","article-title":"Sarcopenia associated with portosystemic shunting is reversed by follistatin","volume":"54","author":"Dasarathy","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1070","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","article-title":"Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial","volume":"3","author":"Becker","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1075","first-page":"62","article-title":"A phase 2 randomized study investigating the efficacy and safety of myostatin antibody LY2495655 versus placebo in patients undergoing elective total hip arthroplasty","volume":"5","author":"Woodhouse","year":"2016","journal-title":"J. Frailty Aging"},{"key":"10.1016\/bs.acc.2021.09.006_bb1080","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1440-1754.2011.02210.x","article-title":"Inherited neuromuscular disorders: pathway to diagnosis","volume":"48","author":"Menezes","year":"2012","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/bs.acc.2021.09.006_bb1085","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ana.10385","article-title":"Loss of myostatin attenuates severity of muscular dystrophy in mdx mice","volume":"52","author":"Wagner","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1090","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/hmg\/ddx431","article-title":"Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice","volume":"27","author":"Tinklenberg","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/bs.acc.2021.09.006_bb1095","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.21338","article-title":"A phase I\/II trial of MYO-029 in adult subjects with muscular dystrophy","volume":"63","author":"Wagner","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1100","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.15_suppl.2516","article-title":"Safety of the antimyostatin monoclonal antibody LY2495655 in healthy subjects and patients with advanced cancer","volume":"30","author":"Jameson","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1105","first-page":"487","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of domagrozumab (PF-06252616), an antimyostatin monoclonal antibody, in healthy subjects","volume":"7","author":"Bhattacharya","year":"2017","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/bs.acc.2021.09.006_bb1110","author":"ClinicalTrials.gov"},{"key":"10.1016\/bs.acc.2021.09.006_bb1115","author":"ClinicalTrials.gov"},{"key":"10.1016\/bs.acc.2021.09.006_bb1120","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/mus.25268","article-title":"Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: results of a randomized, placebo-controlled clinical trial","volume":"55","author":"Campbell","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/bs.acc.2021.09.006_bb1125","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jgs.14927","article-title":"Treatment of sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study","volume":"65","author":"Rooks","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/bs.acc.2021.09.006_bb1130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1164\/rccm.201802-0286OC","article-title":"Activin type II receptor blockade for treatment of muscle depletion in chronic obstructive pulmonary disease. A randomized trial","volume":"199","author":"Polkey","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/bs.acc.2021.09.006_bb1135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/mt.2014.200","article-title":"A phase 1\/2a follistatin gene therapy trial for Becker muscular dystrophy","volume":"23","author":"Mendell","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/bs.acc.2021.09.006_bb1140","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1249\/MSS.0b013e3182178bb4","article-title":"Expression and function of myostatin in obesity, diabetes, and exercise adaptation","volume":"43","author":"Allen","year":"2011","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/bs.acc.2021.09.006_bb1145","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1371\/journal.pone.0006575","article-title":"Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways","volume":"4","author":"Palsgaard","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2021.09.006_bb1150","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1006\/bbrc.2001.4435","article-title":"Inhibition of preadipocyte differentiation by myostatin treatment in 3T3-L1 cultures","volume":"281","author":"Kim","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2021.09.006_bb1155","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1371\/journal.pone.0004937","article-title":"Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity","volume":"4","author":"Guo","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2021.09.006_bb1160","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3390\/nu12051388","article-title":"Ultrasonography of quadriceps femoris muscle and subcutaneous fat tissue and body composition by BIVA in chronic dialysis patients","volume":"12","author":"Battaglia","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/bs.acc.2021.09.006_bb1165","doi-asserted-by":"crossref","first-page":"7307618","DOI":"10.1155\/2017\/7307618","article-title":"Prevalence of sarcopenic obesity in adults with class II\/III obesity using different diagnostic criteria","volume":"2017","author":"Johnson Stoklossa","year":"2017","journal-title":"J. Nutr. Metab."},{"key":"10.1016\/bs.acc.2021.09.006_bb1170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14283\/jfa.2017.33","article-title":"The vicious cycle of myostatin signaling in sarcopenic obesity: myostatin role in skeletal muscle growth, insulin signaling and implications for clinical trials","volume":"7","author":"Consitt","year":"2018","journal-title":"J. Frailty Aging"},{"key":"10.1016\/bs.acc.2021.09.006_bb1175","doi-asserted-by":"crossref","first-page":"7654","DOI":"10.1074\/jbc.M113.529925","article-title":"Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake","volume":"289","author":"Bonala","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2021.09.006_bb1180","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1210\/me.2013-1048","article-title":"Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity","volume":"27","author":"Bonala","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1185","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"10.1016\/bs.acc.2021.09.006_bb1190","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13837","article-title":"Myostatin inhibits glucose uptake via suppression of insulin-dependent and -independent signaling pathways in myoblasts","volume":"6","author":"Liu","year":"2018","journal-title":"Physiol. Rep."},{"key":"10.1016\/bs.acc.2021.09.006_bb1195","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1073\/pnas.1525795113","article-title":"Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice","volume":"113","author":"Camporez","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.acc.2021.09.006_bb1200","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000355796","article-title":"A \"nephrological\" approach to physical activity","volume":"38","author":"Aucella","year":"2014","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/bs.acc.2021.09.006_bb1205","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/oby.20216","article-title":"Aerobic exercise + weight loss decreases skeletal muscle myostatin expression and improves insulin sensitivity in older adults","volume":"21","author":"Ryan","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/bs.acc.2021.09.006_bb1210","article-title":"Muscle-wasting in end stage renal disease in dialysis treatment: a review","volume":"33","author":"Battaglia","year":"2016","journal-title":"G. Ital. Nefrol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.jrn.2013.01.001","article-title":"Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM)","volume":"23","author":"Carrero","year":"2013","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/bs.acc.2021.09.006_bb1220","doi-asserted-by":"crossref","first-page":"32084","DOI":"10.1038\/srep32084","article-title":"Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1","volume":"23","author":"Enoki","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2021.09.006_bb1225","doi-asserted-by":"crossref","first-page":"F84","DOI":"10.1152\/ajprenal.00603.2019","article-title":"Pharmacokinetics and pharmacodynamics of TTI-101, a STAT3 inhibitor that blocks muscle proteolysis in rats with chronic kidney disease","volume":"319","author":"Zhang","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1230","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jcsm.12162","article-title":"Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease","volume":"8","author":"Yu","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/bs.acc.2021.09.006_bb1235","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.kint.2017.02.031","article-title":"The nuclear phosphatase SCP4 regulates FoxO transcription factors during muscle wasting in chronic kidney disease","volume":"92","author":"Liu","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/bs.acc.2021.09.006_bb1240","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2021.09.006_bb1245","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1681\/ASN.2009060571","article-title":"Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy","volume":"21","author":"Zhang","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.kint.2016.07.029","article-title":"The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro\/adipogenic progenitor cells in chronic kidney disease","volume":"91","author":"Dong","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/bs.acc.2021.09.006_bb1255","doi-asserted-by":"crossref","first-page":"809","DOI":"10.4103\/1319-2442.239648","article-title":"Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients","volume":"29","author":"Koyun","year":"2018","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"10.1016\/bs.acc.2021.09.006_bb1260","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-2265.2011.04120.x","article-title":"Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis","volume":"75","author":"Han","year":"2011","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/bs.acc.2021.09.006_bb1265","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s12882-019-1647-9","article-title":"Significance of serum myostatin in hemodialysis patients","volume":"20","author":"Esposito","year":"2019","journal-title":"BMC Nephrol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1270","first-page":"7635459","article-title":"Modulation of myostatin\/hepatocyte growth factor balance by different hemodialysis modalities","author":"Esposito","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/bs.acc.2021.09.006_bb1275","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1038\/s41598-020-62875-2","article-title":"Enhanced myostatin expression and signalling promote tubulointerstitial inflammation in diabetic nephropathy","volume":"10","author":"Verzola","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2021.09.006_bb1280","doi-asserted-by":"crossref","first-page":"H1973","DOI":"10.1152\/ajpheart.00200.2011","article-title":"Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting","volume":"300","author":"Breitbart","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1677\/JOE-07-0072","article-title":"Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse","volume":"194","author":"Artaza","year":"2007","journal-title":"J. Endocrinol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1290","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.RES.0000231290.45676.d4","article-title":"Myostatin regulates cardiomyocyte growth through modulation of Akt signaling","volume":"99","author":"Morissette","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/bs.acc.2021.09.006_bb1295","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCRESAHA.115.304185","article-title":"Myostatin regulates energy homeostasis in the heart and prevents heart failure","volume":"115","author":"Biesemann","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/bs.acc.2021.09.006_bb1300","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1474-9726.2009.00508.x","article-title":"Effects of myostatin deletion in aging mice","volume":"8","author":"Morissette","year":"2009","journal-title":"Aging Cell"},{"key":"10.1016\/bs.acc.2021.09.006_bb1305","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00441-015-2139-2","article-title":"Myostatin induces interstitial fibrosis in the heart via TAK1 and p38","volume":"361","author":"Biesemann","year":"2015","journal-title":"Cell Tissue Res."},{"key":"10.1016\/bs.acc.2021.09.006_bb1310","article-title":"AAV-mediated administration of myostatin pro-peptide mutant in adult Ldlr null mice reduces diet-induced hepatosteatosis and arteriosclerosis","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2021.09.006_bb1315","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2337\/db09-0349","article-title":"Genetic disruption of myostatin reduces the development of pro-atherogenic dyslipidemia and atherogenic lesions in Ldlr null mice","volume":"58","author":"Tu","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/bs.acc.2021.09.006_bb1320","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1152\/physrev.00041.2003","article-title":"Molecular regulation of vascular smooth muscle cell differentiation in development and disease","volume":"84","author":"Owens","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/bs.acc.2021.09.006_bb1325","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri3495","article-title":"Mitogen-activated protein kinases in innate immunity","volume":"13","author":"Arthur","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1330","doi-asserted-by":"crossref","first-page":"407","DOI":"10.23876\/j.krcp.19.085","article-title":"Activin\/myostatin receptor signaling and vascular calcifications in chronic kidney disease: a \"liaison dangereuse\"?","volume":"38","author":"Garibotto","year":"2019","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/bs.acc.2021.09.006_bb1335","doi-asserted-by":"crossref","DOI":"10.5551\/jat.ED129","article-title":"The missing link between sarcopenia and cardiovascular disease in chronic kidney disease?","author":"Morioka","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/bs.acc.2021.09.006_bb1340","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1530\/EJE-12-0512","article-title":"Serum myostatin levels are negatively associated with abdominal aortic calcification in older men: the STRAMBO study","volume":"167","author":"Szulc","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1345","doi-asserted-by":"crossref","first-page":"481","DOI":"10.23876\/j.krcp.19.019","article-title":"Serum myostatin levels are associated with abdominal aortic calcification in dialysis patients","volume":"38","author":"Lee","year":"2019","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/bs.acc.2021.09.006_bb1350","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/SPC.0000000000000013","article-title":"Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders","volume":"7","author":"Smith","year":"2013","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/bs.acc.2021.09.006_bb1355","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/SPC.0b013e32834bddf9","article-title":"Targeting the myostatin signaling pathway to treat muscle wasting diseases","volume":"5","author":"Han","year":"2001","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/bs.acc.2021.09.006_bb1360","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-981-13-1435-3_8","article-title":"Past, present, and future perspective of targeting myostatin and related signaling pathways to counteract muscle atrophy","volume":"1088","author":"Hoogaars","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1365","doi-asserted-by":"crossref","first-page":"12448","DOI":"10.1073\/pnas.1707925114","article-title":"Blockade of activin type II receptors with a dual anti-ActRIIA\/IIB antibody is critical to promote maximal skeletal muscle hypertrophy","volume":"114","author":"Morvan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.acc.2021.09.006_bb1370","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1212\/WNL.0000000000001070","article-title":"Treatment of sporadic inclusion body myositis with bimagrumab","volume":"83","author":"Amato","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/bs.acc.2021.09.006_bb1375","author":"ClinicalTrials.gov"},{"key":"10.1016\/bs.acc.2021.09.006_bb1380","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/ijms21031167","article-title":"Angiotensin (1\u20137) decreases myostatin-induced NF-\u03baB signaling and skeletal muscle atrophy","volume":"21","author":"Aravena","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.acc.2021.09.006_bb1385","first-page":"1","article-title":"Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy","volume":"28","author":"Long","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/bs.acc.2021.09.006_bb1390","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/me.2010-0127","article-title":"Regulation of muscle mass by follistatin and activins","volume":"24","author":"Lee","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1395","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2014-4318","article-title":"Role of activin A and myostatin in human cancer cachexia","volume":"100","author":"Loumaye","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2021.09.006_bb1400","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1152\/japplphysiol.00504.2010","article-title":"Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice","volume":"109","author":"Allen","year":"2010","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/bs.acc.2021.09.006_bb1405","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3945\/jn.113.183996","article-title":"Acute dietary protein intake restriction is associated with changes in myostatin expression after a single bout of resistance exercise in healthy young men","volume":"144","author":"Snijders","year":"2014","journal-title":"J. Nutr."},{"key":"10.1016\/bs.acc.2021.09.006_bb1410","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.3390\/nu12082401","article-title":"Myostatin as a biomarker of muscle wasting and other pathologies\u2014state of the art and knowledge gaps","volume":"12","author":"Baczek","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/bs.acc.2021.09.006_bb1415","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13395-015-0047-5","article-title":"Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay","volume":"5","author":"Bergen","year":"2015","journal-title":"Skelet. Muscle"},{"key":"10.1016\/bs.acc.2021.09.006_bb1420","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.kint.2018.10.010","article-title":"Emerging role of myostatin and its inhibition in the setting of chronic kidney disease","volume":"95","author":"Verzola","year":"2019","journal-title":"Kidney Int."}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242321000809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242321000809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T13:19:18Z","timestamp":1753363158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242321000809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323988377"],"references-count":283,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2021.09.006","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}